Abstract: ABSTRACT INDANOL SUBSTITUTED DIAMINO PYRIMIDINE CARBOXAMIDES AS DUAL ATM/DNA-PK INHIBITORS The present disclosure provides indanol substituted diamino pyrimidine 5 carboxamides compounds of Formula I, its pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, stereoisomers, polymorphs, or pharmaceutically active derivatives thereof as dual ATM/DNA-PK inhibitors. The present disclosure further provides compounds of Formulae Ia, Ib, and Ic, its pharmaceutically acceptable salts, complexes, hydrates, solvates, tautomers, 10 stereoisomers, polymorphs, or pharmaceutically active derivatives thereof. The present disclosure also provides process of preparing said compounds and methods thereof.
DESC:INDANOL SUBSTITUTED DIAMINO PYRIMIDINE CARBOXAMIDES AS DUAL ATM/DNA-PK INHIBITORS ,CLAIMS:AS ATTACHED
| # | Name | Date |
|---|---|---|
| 1 | 202441032214-STATEMENT OF UNDERTAKING (FORM 3) [23-04-2024(online)].pdf | 2024-04-23 |
| 2 | 202441032214-PROVISIONAL SPECIFICATION [23-04-2024(online)].pdf | 2024-04-23 |
| 3 | 202441032214-FORM 1 [23-04-2024(online)].pdf | 2024-04-23 |
| 4 | 202441032214-Proof of Right [22-05-2024(online)].pdf | 2024-05-22 |
| 5 | 202441032214-FORM-26 [22-05-2024(online)].pdf | 2024-05-22 |
| 6 | 202441032214-CORRESPONDENCE-OTHERS [23-04-2025(online)].pdf | 2025-04-23 |
| 7 | 202441032214-COMPLETE SPECIFICATION [23-04-2025(online)].pdf | 2025-04-23 |
| 8 | 202441032214-Request Letter-Correspondence [08-05-2025(online)].pdf | 2025-05-08 |
| 9 | 202441032214-Power of Attorney [08-05-2025(online)].pdf | 2025-05-08 |
| 10 | 202441032214-Form 1 (Submitted on date of filing) [08-05-2025(online)].pdf | 2025-05-08 |
| 11 | 202441032214-Covering Letter [08-05-2025(online)].pdf | 2025-05-08 |
| 12 | 202441032214-CERTIFIED COPIES TRANSMISSION TO IB [08-05-2025(online)].pdf | 2025-05-08 |